Successful Treatment with Imatinib Mesylate in a Case of Minor BCR-ABL-Positive Acute Myelogenous Leukemia

スポンサーリンク

概要

• 論文の詳細を見る
• 2005-04-15

著者

• JINNAI Itsuro

  First Department of Internal Medicine, Saitama Medical School

• BESSHO Masami

  First Department of Internal Medicine, Saitama Medical School

• Bessho Masami

  First Department Of Internal Medicine Saitama Medical School

• ITO Katsuro

  Ogawa Red Cross Hospital

• TOMINAGA Kazunori

  Ogawa Red Cross Hospital

• SUZUKI Toshiya

  Ogawa Red Cross Hospital

• Jinnai Itsuro

  First Department Of Internal Medicine Saitama Medical School

関連論文

• Comparison of leukopenia between cytarabine and behenoyl cytarabine in JALSG AML-89 consolidation therapy
• No beneficial effect from addition of etoposide to daunorubicin,cytarabine,and 6-mercaptopurine in individualized induction therapy of adult acute myeloid leukemia:the JALSG-AML92 study
• Multicenter Prospective Study of Clonal Complications in Adult Aplastic Anemia Patients following Recombinant Human Granulocyte Colony-Stimulating Factor (Lenograstim) Administration
• Successful Treatment with Imatinib Mesylate in a Case of Minor BCR-ABL-Positive Acute Myelogenous Leukemia
• Long-term Follow-up of Patients with Aplastic Anemia and Refractory Anemia Responding to Combination Therapy with Recombinant Human Granulocyte Colony-Stimulating Factor and Erythropoietin
• Therapy-related AML after successful chemotherapy with low dose etoposide for virus-associated hemophagocytic syndrome

スポンサーリンク